STAAR Surgical executive settles performance stock units
STAAR Surgical’s interim co-CEO and President & COO Warren Foust reported routine equity compensation activity tied to performance stock units on May 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
STAAR Surgical’s interim co-CEO and President & COO Warren Foust reported routine equity compensation activity tied to performance stock units on May 15, 2026. Several tranches of 2025 performance stock units vested and were settled into common shares, with a portion of the shares withheld to cover tax obligations at $32.07 per share. Following these transactions, Foust directly held 83,112 shares of common stock.
Insider Trade Summary
32,990 shares exercised/converted
Exercise
12 txns
Insider
Foust Warren
Role
Interim Co-CEO and Pres. & COO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units | 14,662 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 7,331 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 7,331 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 3,666 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 14,662 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 7,460 | $32.07 | $239K |
| Grant/Award | Common Stock | 7,331 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,730 | $32.07 | $120K |
| Grant/Award | Common Stock | 7,331 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,730 | $32.07 | $120K |
| Grant/Award | Common Stock | 3,666 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,865 | $32.07 | $60K |
Holdings After Transaction:
Performance Stock Units — 32,990 contracts (Direct);
Common Stock — 83,112 shares (Direct)
Footnotes (8)
- F1. On May 15, 2026, the first tranche of 14,662 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 7,460 shares were withheld to satisfy taxes .
- F2. On May 15, 2026, the second tranche of 7,331 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes.
- F3. On May 15, 2026, the first tranche of 7,331 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his expanded role as President & Chief Operating Officer vested, of which 3,730 shares were withheld to satisfy taxes.
- F4. On May 15, 2026, the second tranche of 3,666 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his expanded role as President & Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes.
- F5. Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F6. Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F7. Represents the settlement of the first tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F8. Represents the settlement of the second tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Key Figures
PSUs exercised: 32,990 units
Shares withheld for taxes: 16,785 shares
Tax-withholding price: $32.07 per share
+3 more
6 metrics
PSUs exercised
32,990 units
Performance stock units converted to common stock on May 15, 2026
Shares withheld for taxes
16,785 shares
Tax-withholding dispositions at $32.07 per share
Tax-withholding price
$32.07 per share
Price used to value shares withheld for tax liabilities
Shares held after transactions
81,579 shares
Common stock directly owned by Warren Foust after May 15, 2026
Tax-withholding transactions
4 transactions
Code F non-derivative dispositions to satisfy tax obligations
PSU exercises
4 transactions
Code M derivative exercises converting PSUs into common stock
Key Terms
Performance Stock Units, tax-withholding disposition, 2025 Performance Stock Unit Award Program, Compensation Committee, +1 more
5 terms
Performance Stock Units financial
"the first tranche of 14,662 performance stock units ("PSUs") awarded to the Reporting Person"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
tax-withholding disposition financial
"of which 7,460 shares were withheld to satisfy taxes"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
2025 Performance Stock Unit Award Program financial
"awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program")"
Compensation Committee financial
"determined upon certification by the Compensation Committee based on achievement of applicable performance goals"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Rule 16b-3(d) regulatory
"The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported."
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did STAAR Surgical (STAA) report for Warren Foust?
STAAR Surgical reported that interim co-CEO Warren Foust settled multiple tranches of 2025 performance stock units into common shares on May 15, 2026. These were equity compensation-related transactions, not open-market purchases or sales, and reflect routine vesting of long-term incentive awards.
How many performance stock units did Warren Foust settle at STAAR Surgical (STAA)?
Warren Foust exercised or converted a total of 32,990 performance stock units into common stock on May 15, 2026. These units were granted under the 2025 Performance Stock Unit Award Program and vested based on Compensation Committee certification of achievement of applicable performance goals.
What is the role of the 2025 PSU Program in Warren Foust’s STAAR Surgical (STAA) compensation?
The 2025 Performance Stock Unit Award Program grants performance stock units that vest based on specified performance goals. For Warren Foust, tranches tied to his annual equity grant and expanded role vested on May 15, 2026 after Compensation Committee certification, then settled into common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates